QA: Celgene CORP DE in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2017_Celgene_CORP_DE.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 10,867,500,000
1 IntangibleAssetsNetIncludingGoodwill 15,257,600,000
2 PropertyPlantAndEquipmentNet 929,800,000
3 remainder_Assets 1,030,700,000
4 LiabilitiesCurrent 2,959,200,000
5 LiabilitiesNoncurrent 15,559,700,000
6 remainder_Liabilities 2,967,400,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,800,998,847
9 ResearchAndDevelopmentExpense 4,898,105,662
10 remainder_Expenses 1,850,899,894
11 remainder_Revenues 12,280,407,881
12 remainder_NetIncome 78,730,137
13 remainder_ComprehensiveNetIncome -306,734,035
  yvar yval
0 Assets 28,085,600,000
1 Liabilities 21,486,300,000
2 Expenses 9,550,004,403
3 Revenues 12,280,407,881
4 StockholdersEquity 6,599,300,000
5 NetIncome 2,809,133,615
6 ComprehensiveNetIncome 2,655,766,598
7 BaseVar 35,893,888,228
8 EconomicCapitalRatiobeforeLimitedLiability 0.688
9 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time